Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optiswiss is a Swiss ophthalmic optics company that develops, manufactures, and sells prescription spectacle lenses and related optical products for opticians. The company operates as an independent lens manufacturer with its main technology and production site in Basel, Switzerland, and markets itself as Switzerland's leading lens manufacturer. Its portfolio includes single-vision, progressive, office, kids, sport, sunglass, and coated ophthalmic lenses, including branded technologies such as BIOMETRICS, S-Fusion, Optiplas, and CLEEN. Optiswiss appears to be a commercial-stage medtech business rather than a drug-development biotech or pharma company, with revenues generated from finished optical products and B2B services for eye care professionals. The company also emphasizes Swiss manufacturing, sustainability, and collaborations with external experts, universities, and institutes in research and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optiswiss.